Comparison of outcomes using radiotherapy or brachytherapy after  resection of primary adenoid cystic carcinoma in oral and maxillofacial regions

We wished to investigate the outcome of surgery combined with external-beam radiotherapy (EBRT) or brachytherapy (125I seeds) for the treatment of primary adenoid cystic carcinoma (ACC) of the oral and maxillofacial region. Data of patients with primary ACC were reviewed retrospectively. Patients were divided into EBRT and brachytherapy groups. Wide tumor excision was done to achieve negative margins. Standard radiotherapy in the EBRT group was 60  Gy. A treatment-planning system was used to create implantation plans with a prescribed dose of 60–120 Gy and 125I seeds were implanted postoperatively.

Source: Brachytherapy - October 14, 2020 Category: Cancer & Oncology Authors: C. Li, S.M. Liu, L. Zheng, M.W. Huang, Y. Shi, X.M. Lv, J.G. Zhang, X. Peng, J. Zhang Source Type: research